SunHydrogen ab dem Jahre 2021
Seite 1 von 22 Neuester Beitrag: 04.10.24 09:28 | ||||
| Eröffnet am: | 06.06.21 12:36 | von: AndySA | Anzahl Beiträge: | 532 |
| Neuester Beitrag: | 04.10.24 09:28 | von: HonestMeyer | Leser gesamt: | 209.332 |
| Forum: | Hot-Stocks | Leser heute: | 97 | |
| Bewertet mit: |  | |||
| Seite: < 1 | 2 | 3 | 4 | 20 | 21 | 22 22 > | ||||
Das der Nachbarthread nicht den Namen "sunhydrogen" sondern noch "Hypersolar" heißt und dieses hYPERSOLAR thread ein EXIL für Kritiker darstellen soll ist der einzige Grund dafür, dass ich damals vor dem Investment schlecht informiert war. Beide Seiten sollten in einem Thread diskutieren, und eigtl, sollte der Hypersolar thread schon in sunhydrogen geändert werden...
Deswegen sollte jetzt etwas neues versucht werden, um die serösität zu steigern!
Optionen
| Boardmail an "AndySA" |
Wertpapier: SunHydrogen Inc |
Das ist hinterher leicht gesagt, aber SH bzw. Hypersolar zuvor hat das immer ganz anders dargestellt. Da wurde von Plants, 100 Demonstrationsmodulen und auch von Walmart und Co. fabuliert. Alles nicht eingetroffen. Nichts davon. Also bitte mal bei den Fakten bleiben und sich vollständig einlesen ab 2011. NmM.
Schönmalerei finde ich genau wenig zielführend wie Schönrednerei.
Optionen
| Boardmail an "Joe2000" |
Wertpapier: SunHydrogen Inc |
SunHydrogen Announces Joint Development Agreement with Honda R&D Co., LTD
https://www.sunhydrogen.com/news-posts/ctf
Die letzte Zeit zeigt sich immer häufiger, dass die Entwicklungen von SunHydrogen an vorhandene Prozesse angepasst werden müssen und nicht andersherum. Nun auch im Falle von CTF Solar:
" to create a 100 cm² hydrogen module that facilitates hydrogen production with minimal modifications to the existing manufacturing process. "
Die Frage, welchen Einfluss die vorhandenen Prozesse der Entwicklungspartner auf den Preis des SH-Produkts haben werden, wird man den Aktionären vermutlich erst ganz am Ende offenbaren. NmM.
Über die Finanzierung SHs aber, die Art der Finanzierung und wie jederzeit das Exit dieser Finanzierung aussehen könnte, wird so gut wie überhaupt nicht gesprochen. Und dabei liegt hierin der zu erwartende Worst Case für alle Shareholder. NmM.
Gespannt bin ich auf die technischen Komponenten, die aus Gen2 übrig bleiben und ob Gen3 in 2025 tatsächlich ins Leben gerufen wird.
We were formed in February 2009 and are currently developing a new technology that has not yet gained market acceptance. There can be no assurance that we will ever operate profitably or that we will have adequate working capital to meet our obligations as they become due.
"...that has not yet gained market acceptance."
As of June 30, 2024, we have an accumulated deficit of $91,852,243. For the year ended June 30, 2024, we incurred a net loss of $9,881,203. We expect to incur net losses until we are able to realize revenues to fund our continuing operations. We may fail to achieve any or significant revenues from sales or achieve or sustain profitability. Accordingly, we may never be profitable or be able to maintain profitability.
Defizit bei 91,8 Millionen Dollar.
As of June 30, 2024, we have outstanding shares of redeemable Series C Preferred Stock with an aggregate stated value of $885,100 that are convertible into common stock at a fixed conversion price of $0.00095 (see Note 3 to the financial statements included in this report). We anticipate that our issuance of common stock upon conversion of outstanding preferred shares will result in dilution to holders of our common stock, which may have a negative effect on the price of our common stock. In addition, as of June 30, 2024, we have outstanding warrants to purchase 78,095,239 shares of common stock and options to purchase 266,894,499 shares of common stock, and our issuance of shares of common stock upon exercise of outstanding warrants or options may result in additional dilution to our stockholders.
As of June 30, 2024, we had a working capital surplus of $42,386,683, compared to a working capital surplus of $47,689,381 as of June 30, 2023. This decrease in working capital surplus of $5,302,698 was primarily due to a decrease in marketable securities redeemed, and the change in fair value of a short-term investment.
Cash flow used in operating activities was $1,842,726 for the year ended June 30 2024, compared to $4,262,085 for the year ended June 30, 2023. The decrease of $2,419,359 in cash used by operating activities was primarily due to an increase in non-cash expense offset by a decrease in net loss. The Company has had no revenues during the years ended June 30, 2024 and 2023.
Cash provided by investing activities for the year ended June 30, 2024 was $2,920,237, compared to $11,101,386 for the year ended June 30, 2023. The decrease of $8,181,149 in cash provided by investing activities was primarily due to a decrease in the net redemption of marketable securities offset by a decrease in the purchase of related party investments, the purchase of a related party convertible note, and an increase in the redemption of short-term investments in corporate securities.
Cash provided by financing activities during the year ended June 30, 2024 was $781,295, compared to $2,665,203 for the year ended June 30, 2023. The decrease in cash provided by financing activities was primarily due to a decrease in net proceeds from purchase agreements.
Das über die letzten 14 Jahre per Aktienverkauf eingenommene Cash reicht noch für ca. 6-8 Jahre. Für den Aufbau einer eigenen Produktion wird es in ca. 3-4 Jahren eng. Man kann sich später aber auch in Abhängigkeiten begeben und auf die $2,5/kg verzichten, mit denen man seit Jahren Werbung macht. Dann kann Tim Young aber trotzdem beruhigt in Rente gehen...Dank Disclaimer und Safe Harbour Statements. NmM.
16.§SUBSEQUENT EVENTS
Management evaluated subsequent events as of the date of the financial statements pursuant to ASC TOPIC 855 and had the following subsequent events to report.
On September 6, 2024, the Company issued 32,051,283 shares of common stock at a price of $0.0156 per share in the amount of $500,000, pursuant to a purchase notice under the purchase agreement.
On September 13, 2024, the Company issued 37,055,336 shares of common stock at a price of $0.02024 per share in the amount of $750,000, pursuant to a purchase notice under the purchase agreement.
On September 16, 2024, Mark Richardson resigned as a director of SunHydrogen, Inc. Mr. Richardson’s resignation will be effective September 30, 2024. Mr. Richardson’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
On September 30, 2024, the Company issued 49,407,115 shares of common stock at a price of $0.02024 per share in the amount of $1,000,000, pursuant to a purchase notice under the purchase agreement.